Pusad Hospital & Research Centre Profile
Key Indicators
- Authorised Capital ₹ 2.40 Cr
as on 26-07-2024
- Paid Up Capital ₹ 2.40 Cr
as on 26-07-2024
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.00 Cr
as on 26-07-2024
- Revenue -24.59%
(FY 2023)
- Profit -75.09%
(FY 2023)
- Ebitda -59.77%
(FY 2023)
- Net Worth 8.27%
(FY 2023)
- Total Assets -0.47%
(FY 2023)
About Pusad Hospital & Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.40 Cr and a paid-up capital of Rs 2.40 Cr.
The company currently has active open charges totaling ₹8.00 Cr.
Virendrakumar Papalkar, Sanjay Agrawal, and Satish Chiddarwar serve as directors at the Company.
- CIN/LLPIN
U85110MH2010PTC204413
- Company No.
204413
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jun 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Pusad, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pusad Hospital & Research Centre?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Virendrakumar Papalkar  | Director | 17-Jun-2010 | Current |
| Sanjay Agrawal | Director | 17-Jun-2010 | Current |
| Satish Chiddarwar | Director | 01-Aug-2012 | Current |
Financial Performance of Pusad Hospital & Research Centre.
Pusad Hospital & Research Centre Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 24.59% decrease. The company also saw a substantial fall in profitability, with a 75.09% decrease in profit. The company's net worth moved up by a moderate rise of 8.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pusad Hospital & Research Centre?
In 2023, Pusad Hospital & Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 01 Dec 2021 | ₹9.00 M | Open |
Bank Of India Creation Date: 22 May 2014 | ₹7.10 Cr | Open |
How Many Employees Work at Pusad Hospital & Research Centre?
Pusad Hospital & Research Centre has a workforce of 122 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pusad Hospital & Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pusad Hospital & Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
